Cargando…

Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia

Glucocorticoids (GCs) and topoisomerase II inhibitors are used to treat acute lymphoblastic leukaemia (ALL) as they induce death in lymphoid cells through the glucocorticoid receptor (GR) and p53 respectively. Mechanisms underlying ALL cell death and the contribution of the bone marrow microenvironm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qattan, Malak Yahia, Bakker, Emyr Yosef, Rajendran, Ramkumar, Chen, Daphne Wei-Chen, Saha, Vaskar, Liu, Jizhong, Zeef, Leo, Schwartz, Jean-Marc, Mutti, Luciano, Demonacos, Constantinos, Krstic-Demonacos, Marija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459454/ https://www.ncbi.nlm.nih.gov/pubmed/28582465 http://dx.doi.org/10.1371/journal.pone.0178606

Ejemplares similares

Roadmap to personalized medicine
por: Qattan, Malak, et al.
Publicado: (2012)

Insight into glucocorticoid receptor signalling through interactome model analysis
por: Bakker, Emyr, et al.
Publicado: (2017)

Sirtuins: Molecular Traffic Lights in the Crossroad of Oxidative Stress, Chromatin Remodeling, and Transcription
por: Rajendran, Ramkumar, et al.
Publicado: (2011)

Protein disulfide isomerase A1-associated pathways in the development of stratified breast cancer therapies
por: Bakker, Emyr Yosef, et al.
Publicado: (2022)

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
por: Guazzelli, Alice, et al.
Publicado: (2019)

Intratumor microbiota as a novel potential prognostic indicator in mesothelioma
por: Pentimalli, Francesca, et al.
Publicado: (2023)

The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression
por: Lynch, James T, et al.
Publicado: (2010)

Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells
por: Leung, Travis, et al.
Publicado: (2013)

p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification
por: Tian, Kun, et al.
Publicado: (2018)

Dynamics of DNA Damage Induced Pathways to Cancer
por: Tian, Kun, et al.
Publicado: (2013)

Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state
por: Alhammad, Rashed, et al.
Publicado: (2020)

Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress
por: Garva, Richa, et al.
Publicado: (2019)

The role of phosphorylated glucocorticoid receptor in mitochondrial functions and apoptotic signalling in brain tissue of stressed Wistar rats
por: Adzic, Miroslav, et al.
Publicado: (2009)

Modeling the Mechanism of GR/c-Jun/Erg Crosstalk in Apoptosis of Acute Lymphoblastic Leukemia
por: Chen, Daphne Wei-Chen, et al.
Publicado: (2012)

Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain
por: Adzic, Miroslav, et al.
Publicado: (2009)

Targeting hypoxic response for cancer therapy
por: Paolicchi, Elisa, et al.
Publicado: (2016)

Site-specific and dose-dependent effects of glucocorticoid receptor phosphorylation in yeast Saccharomyces cerevisiae
por: Popovic, Natasa, et al.
Publicado: (2010)

miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway
por: Kuroda, Kengo, et al.
Publicado: (2017)

Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer
por: Alhebshi, Hasen, et al.
Publicado: (2021)

Is There Already a Need of Reckoning on Cancer Immunotherapy?
por: Correale, Pierpaolo, et al.
Publicado: (2021)

Antimicrobial peptide FF/CAP18 induces apoptotic cell death in HCT116 colon cancer cells via changes in the metabolic profile
por: KURODA, KENGO, et al.
Publicado: (2015)

Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
por: Fiorillo, Marco, et al.
Publicado: (2016)

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma
por: Meirson, Tomer, et al.
Publicado: (2022)

Circular and linear: a tale of aptamer selection for the activation of SIRT1 to induce death in cancer cells
por: Al-Sudani, Basma, et al.
Publicado: (2020)

A Novel Mechanism of Ataxia Telangiectasia Mutated Mediated Regulation of Chromatin Remodeling in Hypoxic Conditions
por: Likhatcheva, Maria, et al.
Publicado: (2021)

Identification of novel Notch target genes in T cell leukaemia
por: Chadwick, Nicholas, et al.
Publicado: (2009)

Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia
por: Li, Xingjian, et al.
Publicado: (2019)

Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton
por: Johnson, Suzanne M., et al.
Publicado: (2017)

The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
por: Hu, Xingdi, et al.
Publicado: (2019)

Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia
por: Sidhu, Jasmeet, et al.
Publicado: (2021)

Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia
por: Olsson, A, et al.
Publicado: (2007)

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells
por: Hofbauer, Sebastian W., et al.
Publicado: (2015)

Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells
por: Lai, Xun, et al.
Publicado: (2021)

Temporal changes in incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council Trials, 1985–2001
por: Krishnan, Shekhar, et al.
Publicado: (2009)

Immunotherapy in leukaemia: Immunotherapy in leukaemia
por: Mu, Xingmei, et al.
Publicado: (2023)

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
por: Barbier, Valerie, et al.
Publicado: (2020)

METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia
por: Pan, Zhi‐peng, et al.
Publicado: (2021)

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
por: Parker, Catriona, et al.
Publicado: (2010)

Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer
por: Rajendran, Ganeshkumar, et al.
Publicado: (2021)

Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial
por: Parker, Catriona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a4arc2o996e5uvkt1e8km115sj